RARE Even with the recent setback on trial fails, Analysts consensus is bullish between 45 to 75 from here. They have pipeline depth and good news will come. Will go to 30 in Jan.
Ultragenyx Pharmaceutical Inc.
No trades
What traders are saying
RARE Even with the recent setback on trial fails, Analysts consensus is bullish between 45 to 75 from here. They have pipeline depth and good news will come. Will go to 30 in Jan.